Drug details

Elelyso (taliglucerase alfa)

type of Enzymes, Metabolic

Elelyso (taliglucerase alfa) for injection is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy (ERT) for adults with a confirmed diagnosis of type 1 Gaucher disease.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• vomiting,
• skin rash,
• lightheadedness,
• dizziness,
• wheezing,
• cough,
• redness
• itching, and
• chest tightness,
• flushing (warmth, redness, or tingly feeling),
• throat irritation,

The following drugs are related to Elelyso, either as a replacement or used together:

• Cerdelga (eiglustat capsules)
• Cerezyme (imiglucerase)
• Zavesca (miglustat)